Lyubica Dabich

1.1k total citations
29 papers, 767 citations indexed

About

Lyubica Dabich is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Lyubica Dabich has authored 29 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 8 papers in Hematology. Recurrent topics in Lyubica Dabich's work include Systemic Sclerosis and Related Diseases (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Lyubica Dabich is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (5 papers). Lyubica Dabich collaborates with scholars based in United States and Canada. Lyubica Dabich's co-authors include C. J. D. Zarafonetis, S E Rivkin, Weick Jk, Steve Dahlberg, Earl N. Metz, David Head, Mark B. Orringer, Herbert Sloan, MB Orringer and Jay S. Orringer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lyubica Dabich

27 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyubica Dabich United States 15 284 278 216 183 137 29 767
J. S. Malpas United Kingdom 13 193 0.7× 289 1.0× 217 1.0× 283 1.5× 74 0.5× 35 861
Walter Feremans Belgium 16 149 0.5× 601 2.2× 142 0.7× 178 1.0× 57 0.4× 58 981
Leroy Fass United States 13 215 0.8× 167 0.6× 62 0.3× 274 1.5× 42 0.3× 26 747
N Gratecos France 13 241 0.8× 704 2.5× 193 0.9× 306 1.7× 32 0.2× 46 1.2k
Adina Cioc United States 15 113 0.4× 276 1.0× 121 0.6× 264 1.4× 92 0.7× 33 793
S H Advani India 15 98 0.3× 261 0.9× 156 0.7× 162 0.9× 61 0.4× 50 616
Jane Mercieca United Kingdom 10 215 0.8× 467 1.7× 48 0.2× 215 1.2× 81 0.6× 14 835
G. B. Vogelsang United States 17 81 0.3× 963 3.5× 160 0.7× 267 1.5× 60 0.4× 28 1.2k
J M Falletta United States 12 153 0.5× 286 1.0× 298 1.4× 130 0.7× 42 0.3× 19 834
Pedro Zubizarreta Argentina 18 102 0.4× 264 0.9× 320 1.5× 437 2.4× 113 0.8× 59 986

Countries citing papers authored by Lyubica Dabich

Since Specialization
Citations

This map shows the geographic impact of Lyubica Dabich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyubica Dabich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyubica Dabich more than expected).

Fields of papers citing papers by Lyubica Dabich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyubica Dabich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyubica Dabich. The network helps show where Lyubica Dabich may publish in the future.

Co-authorship network of co-authors of Lyubica Dabich

This figure shows the co-authorship network connecting the top 25 collaborators of Lyubica Dabich. A scholar is included among the top collaborators of Lyubica Dabich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyubica Dabich. Lyubica Dabich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krishnan, Koyamangalath, et al.. (2008). Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis. Clinical & Laboratory Haematology. 16(3). 285–289. 6 indexed citations
2.
Krishnan, Koyamangalath, Fernando J. Martínez, Richard T. Jones, et al.. (1994). HB Washtenaw [βT11(A8)VAL-PHE]: An Electrophoretically Silent, Unstable, Low Oxygen Affinity Variant Associated with Anemia and Chronic Cyanosis. Hemoglobin. 18(4-5). 285–295. 14 indexed citations
3.
Sk, Das, et al.. (1993). Effect of cold stress on coronary sinus blood flow in patients with scleroderma.. PubMed. 4(2). 62–5. 4 indexed citations
4.
Sp, Balcerzak, et al.. (1992). Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.. PubMed. 6(7). 708–14. 22 indexed citations
5.
Karanes, Chatchada, John Crowley, Bill L. Tranum, et al.. (1990). Aclacinomycin A in the treatment of multiple myeloma: A Southwest Oncology Group study. Investigational New Drugs. 8(1). 101–104. 3 indexed citations
6.
Zarafonetis, C. J. D., et al.. (1989). Retrospective Studies in Scleroderma: Pulmonary Findings and Effect of Potassium <i>p</i>-Aminobenzoate on Vital Capacity. Respiration. 56(1-2). 22–33. 6 indexed citations
7.
Dahlberg, Steve, David Head, Lyubica Dabich, et al.. (1989). Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood. 73(1). 57–63. 113 indexed citations
8.
Dahlberg, Steve, David Head, Lyubica Dabich, et al.. (1989). Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood. 73(1). 57–63. 95 indexed citations
9.
Dabich, Lyubica & Marcia K. Liepman. (1988). Cisplatin, VP-16-213 and MGBG (Methylglyoxal bis guanylhydrazone) combination chemotherapy in refractory lymphoma, a phase II study. Investigational New Drugs. 6(3). 231–237. 4 indexed citations
10.
Zarafonetis, C. J. D., et al.. (1988). Retrospective studies in scleroderma: skin response to potassium para-aminobenzoate therapy.. PubMed. 6(3). 261–8. 20 indexed citations
11.
Zarafonetis, C. J. D., et al.. (1986). Potassium para-aminobenzoate and liver function test findings. Journal of the American Academy of Dermatology. 15(1). 144–149. 5 indexed citations
12.
Dabich, Lyubica, William D. Ensminger, Kenneth S. Zuckerman, Richard Wheeler, & Albert F. LoBuglio. (1985). High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.. PubMed. 12(2 Suppl 3). 212–7. 6 indexed citations
13.
Se, Jones, et al.. (1982). Surgical restaging of Hodgkin's disease.. PubMed. 66(4). 751–7. 10 indexed citations
14.
Orringer, MB, Jay S. Orringer, Lyubica Dabich, & C. J. D. Zarafonetis. (1981). Combined Collis gastroplasty--fundoplication operations for scleroderma reflux esophagitis.. PubMed. 90(4). 624–30. 51 indexed citations
15.
Aminoff, David, et al.. (1980). Sialic acid content of erythrocytes in normal individuals and patients with certain hematologic disorders. American Journal of Hematology. 9(4). 381–389. 19 indexed citations
16.
Dabich, Lyubica. (1980). Adult Acute Nonlymphocytic Leukemias. Medical Clinics of North America. 64(4). 683–704. 3 indexed citations
17.
Dabich, Lyubica. (1972). Digital Arteries in Patients With Scleroderma. Archives of Internal Medicine. 130(5). 708–708. 66 indexed citations
18.
Levine, Paul H., et al.. (1972). Infectious mononucleosis prior to acute leukemia: A possible role for the epstein-barr virus. Cancer. 30(4). 875–880. 21 indexed citations
19.
20.
Dabich, Lyubica, et al.. (1967). Late effects of thorotrast on the peripheral blood and bone marrow.. PubMed. 32(6). 296–300.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. S. Malpas Breakdown of academic impact, for papers by Walter Feremans Breakdown of academic impact, for papers by Leroy Fass Breakdown of academic impact, for papers by N Gratecos Breakdown of academic impact, for papers by Adina Cioc Breakdown of academic impact, for papers by S H Advani Breakdown of academic impact, for papers by Jane Mercieca Breakdown of academic impact, for papers by G. B. Vogelsang Breakdown of academic impact, for papers by J M Falletta Breakdown of academic impact, for papers by Pedro Zubizarreta
Rankless by CCL
2026